The global demand for Pet Grade Hyaluronic Acid Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Hyaluronic acid, hyaluronan, or sodium hyaluronate is naturally present in the animal body. It is found in the highest concentrations of fluids in the eyes and joints. It is made by bacteria in the laboratory or extracted from rooster combs. Animal prefers hyaluronic acid treatment for various joint disorders, including osteoarthritis, arthritic conditions, inflammatory diseases of the muscles and tendons of horses, and joint pain. It can be taken by mouth or injected into the affected joint by a healthcare professional. HA injections in animal models improved the healing process and play protective role and low or no effect.
Market Dynamics
The global pet grade hyaluronic acid market is projected to grow with the rising prevalence of joint diseases such as osteoarthritis, rheumatoid arthritis among the animal's population. Injections of hyaluronic acid (HA) are widely used for the symptomatic treatment of osteoarthritis (OA). Changing perceptions towards pets and growing awareness regarding the benefits of mobile pet care services are several factors to influence the market's growth. Increasing inclination towards value-added nutrition products for pets or animals is also favoring the development of the market. Manufacturers are adding hyaluronic acid to the nutritional supplement to boost animal's bone health. Key market participants are working to extract or develop hyaluronic acid from alternatives processes or sources such as bio-fermentation using genetically modified organisms.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pet grade hyaluronic acid. The growth and trends of pet grade hyaluronic acid industry provide a holistic approach to this study.
Market Segmentation
This section of the pet grade hyaluronic acid market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Preparation Method
- Microbial Fermentation
- Animal Tissue
By Application
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Pet Grade Hyaluronic Acid market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Pet Grade Hyaluronic Acid Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pet grade hyaluronic acid market include Bloomage BioTechnology, Shandong Focuschem Biotech, Neimenggu Fufeng Biotechnologies, Shandong AWA Biopharm, Kewpie, Contipro, Givaudan. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.